Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 8,710 shares at $5.68 ($49K) on 2019-09-30, disclosed to the SEC on 2019-10-02.
Scheduled purchase ($49k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-09-25 | $101K | — | Filing → |